Yüklüyor......
Complications after CD19+ CAR T-Cell Therapy
SIMPLE SUMMARY: CD19+ Chimeric antigen receptor (CAR) T-cells are used against CD19+ hematologic malignancies, such as high-grade B-cell lymphoma and acute lymphoblastic leukemia. Since this is a relatively new treatment approach, not all potential side effects are well described, and the underlying...
Kaydedildi:
| Yayımlandı: | Cancers (Basel) |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7699604/ https://ncbi.nlm.nih.gov/pubmed/33228221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12113445 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|